Government Relations

Throughout BioOhio’s twenty-eight year history, the organization has worked with local, state and federal agencies, officials and representatives to promote Ohio’s bioscience industry, BioOhio members, and the health and prosperity of Ohio.

BioOhio also proudly serves as the Ohio affiliate of national industry groups Advanced Medical Technology Association (AdvaMed), Biotechnology Innovation Organization (BIO), Medical Device and Manufacturing Association (MDMA), and Pharmaceutical Research and Manufacturers of America (PhRMA). BioOhio’s partner in government relations is member firm G2G.

If you would like to get involved or have questions about these issues, please contact John F. Lewis, Jr., BioOhio President and CEO, at jlewis@bioohio.com.

Ohio-DC-400

Policy Notice

Our organization supports step therapy legislation in Ohio. Ohio House Bill 72 and Ohio Senate Bill 56 are companion bills, designed to bring needed reforms to “fail first” practices, when health plans deny coverage of a medication. Find out more at ReformStepTherapy.com and join us in supporting these bills.

Policy Notice

In November, 2017, there is an upcoming ballot issue on prescription drug pricing in Ohio. Click here to learn more.

BIO-Action-logo-200

Become an Advocate for Biotechnology

On the forefront of furthering lifesaving, landmark innovation, the biotechnology industry in 2017 promises to continue to heal, fuel and feed the world. Learn about the key issues facing our biotechnology sectors, and how to get involved and share your biotechnology story with BIOAction.

Purpose of Advocacy, Government Relations and Public Policy: Educate, Engage, & Change

Public officials make decisions every day about funding, regulatory rulings, and a myriad of other policy initiatives that have substantial impact on Ohio’s bioscience community. The voice of Ohio’s bioscience community is a crucial component of that conversation. Legislators rely on industry leaders and constituents for on-the-ground, real-time understanding of the industry. An effective advocacy campaign can:

  • Educate elected officials – most are not industry experts and value constituent guidance
  • Influence regulations within executive agencies
  • Shape legislative process and policies – industry has the unique experiences and job-creating power that makes bioscience issues a top priority
  • Affect elections, polling, and the media – ensure support of decision-makers who champion constituents’ causes
  • Lead to active partnerships across the bioscience business community

Why Constituents Matter

One of the strongest guiding forces behind state and federal policy is the position of lawmakers’ constituents. Many lawmakers refer to their constituents as their boss. Individual voices matter because they have the power to influence representatives in the following ways:

  • Increase their credibility with the community
  • Employ other constituents
  • Help with fundraising and re-election efforts
  • Secure local media coverage to highlight activities in their district
  • Mark the district and the state of Ohio as nationwide leaders in advancements within the bioscience field

As individuals, or representatives of companies and organizations, constituents can engage with state and federal legislators, communicate with them on issues that impact their company or institution, educate these officials with facts versus opinions, and be part of the process to effect change.

Read about issues and policies affecting the bioscience industry

Keep up with activity at the State and Federal levels with content from our national partners, AdvaMed, BIO, MDMA and PhRMA, and our advocacy consulting firm, G2G, via links below to content in our Blow & News section.

All Advocacy Posts   |   Legislative Updates from G2G

Advocacy & Government Items in the News

Updates from BIO and the Council of State Bioscience Associations